Skip to main content
CSBR logo
CSBR
(NASDAQ)
Champions Oncology, Inc.
$5.05-- (--)
Loading... - Market loading

Champions Oncology (CSBR) Stock Price & Financial Analysis

Champions Oncology Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.05 - $5.21
52-Week High$8.74
52-Week Low$4.83
Open$5.11
Volume15.29K
Average Volume (3M)10.19K
Market Cap72.49M
Shares Outstanding13.89M
Price to Sales (P/S)1.22
Price to Book (P/B)18.40
EV/EBITDA216.59
Revenue (TTM)59.42M
Net Income (TTM)-1.08M
Free Cash Flow (TTM)-5.04M
EPS (TTM)$-0.08
Profit Margin-1.82%
Operating Margin-1.77%
Return on Equity (ROE)-27.49%
Debt to Equity0.76
50-Day MA$5.48
200-Day MA$6.08
52-Week Change-25.74%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Champions Oncology

What is the current stock price for CSBR?

As of the latest trading session, CSBR stock trades at $5.05. The 52-week range is $4.83–$8.74, with a day range of $5.05–$5.21.

What is the P/E ratio for CSBR?

The P/E ratio (Price-to-Earnings) for CSBR is shown in the Key Statistics section. This valuation metric helps compare Champions Oncology, Inc. to industry peers.

Does CSBR pay dividends?

Champions Oncology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CSBR?

Based on 1 analyst, the consensus for CSBR is Buy.

What is the market cap of CSBR?

Champions Oncology's market capitalization is $70.1M, classifying it as a micro-cap company. Champions Oncology operates in the Healthcare sector within the Biotechnology industry.